SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People
Clinical trial NCT06048393 · UNKNOWN
Trial details
- NCT number
- NCT06048393
- Sponsor
- Sinovac Life Sciences Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2023-09-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.